Astoria, New York Clinical Trials

A listing of Astoria, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 414 clinical trials
Systematic Evaluation of Ablation Techniques for Non-Paroxysmal Atrial Fibrillation.

The purpose of this study is to evaluate the safety and effectiveness of empirical posterior wall isolation (PWI), left atrial appendage electrical isolation (LAAEI) and coronary sinus isolation (CSI) when compared to pulmonary vein isolation (PVI) alone: PVI alone, PVI + PWI, PVI + PWI + LAAEI, PVI + PWI …

dyspnea
fibrillation
pulmonary vein isolation
left ventricular dysfunction
atrial fibrillation
Montefiore Medical Center
 (7.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients

A multicenter, randomized, adaptive allocation clinical trial to determine if increasing durations of induced hypothermia are associated with an increasing rate of good neurological outcomes and to identify the optimal duration of induced hypothermia for neuroprotection in comatose survivors of cardiac arrest.

coma
induced hypothermia
hypothermia
life support
cardiac arrest
NYP Columbia University Medical Center
 (4.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +12 other locations
Manhattan Vision Screening and Follow-Up Study

The investigators are conducting a 5-year prospective, cluster-randomized controlled trial, funded by the Centers for Disease Control (CDC), which provides vision screenings to underserved, vulnerable New York City residents living in affordable housing buildings in Harlem and Washington Heights.

vision screening
Columbia University
 (4.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Families Children and Teachers Thriving Together

The current study examines the impact of ParentCorps in high-poverty district schools in New York City (NYC). The study is conducted within the context of the NYC Department of Education (DOE) Pre-K Thrive initiative. As part of this initiative, the Center for Early Childhood Health and Development (CEHD) at NYU …

inspire
cehd
NYU Langone Health
 (3.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

paclitaxel
adjuvant
carboplatin
olaparib
carcinoma
Research Site
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +94 other locations
Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of CC-94676 in Subjects With Metastatic Castration-Resistant Prostate Cancer

This is a first in human study to assess the safety, tolerability, PK, PD and preliminary efficacy of CC-94676 in men with progressive metastatic castration-resistant prostate cancer.

adenocarcinoma
metastatic hormone refractory prostate cancer
orchiectomy
endocrine therapy
castration-resistant prostate cancer
Memorial Sloan-Kettering Cancer Center
 (1.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
ctgov trial 2

    dddd

Test Site
 (3.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Primary Objectives: Dose Escalation Part A: To determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory multiple myeloma (RRMM), and determine the recommended Phase 2 dose (RP2D) for the subsequent Expansion Part B Dose Expansion Part B: To assess the …

monoclonal antibodies
lenalidomide
daratumumab
pomalidomide
refractory multiple myeloma
Investigational Site Number 8400001
 (1.7 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +7 other locations
Test Campaign Performance Report  

Test Campaign Performance Report

Site Test A
 (5.0 away)
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
Test CPR 2  

Test CPR 2

Site Test A
 (5.0 away)
  • 0 views
  • 19 Feb, 2024
  • +2 other locations